|
This diarrheal
disease is caused by a recently identified coccidian protozoa (Cyclospora
cayetanensis). This clinical syndrome consists of watery
diarrhea (6 or more stools/day), nausea, anorexia, abdominal
cramping, fatigue and weight loss; fever is rare. The median
incubation period is about 1 week. Cyclospora can invade
the jejunal epithelium and produce enteritis. Diarrhea in the
immunocompetent can be prolonged but is self-limited, and lasts
9-43 days according to various reports; mean duration of
organism shedding was 23 days in Peruvian children. In the
immunocompromised, diarrhea lasted for months in some patients.
It has also been associated with prolonged diarrhea in travelers
to Asia, the Caribbean, Mexico and Peru.
Diagnosis is
made by identification of the 8-9 µm size oocysts, about twice
the size of Cryptosporidium parvum in wet mount under
phase contrast microscopy. A modified acid-fast stain can be
used. Organisms fluoresce under ultraviolet illumination.
Transmission
appears to be primarily waterborne, and occurs either through
drinking or swimming in contaminated water; there have been
international outbreaks involving thousands of persons traced to
raspberries from Guatemala that occurred in at least 3
successive years during the late 1990s. Other vehicles have
included basil and lettuce. Outbreaks have a seasonal pattern,
with warmer months predominating in reported cases.
The way in which
the produce was contaminated was not determined for any of the
outbreaks, in part because methods for detecting Cyclospora
on produce and in other environmental samples are insensitive to
low levels of the parasite. Produce should be washed thoroughly
before it is eaten; however, this practice does not eliminate
the risk of Cyclospora. Health care providers should
consider the diagnosis of Cyclospora infection in persons
with prolonged diarrheal illness and request stool specimens so
that specific tests for this parasite can be made.
Cyclosporiasis can be treated
with a 7 day course of oral trimethoprim (TMP)-sulfamethoxazole
(SMX) (for adults, 160 mg TMP plus 800 mg SMX twice daily; for
children, 5 mg/kg TMP plus 25 mg/kg SMX twice daily). In
patients who are not treated, illness can be protracted, with
remitting and relapsing symptoms. Treatment regimens for
patients who cannot tolerate sulfa drugs have not been
identified. |